Neurolief (נוירוליף)

Coral Springs, Florida, United States

Neurolief is dedicated to bringing relief to patients with chronic neurological and neuropsychiatric disorders. The company has created a digital therapeutics platform of clinically proven neuromodulation-based solutions that can be delivered to patients at home or in the community. Neurolief's Relivion is a noninvasive, multichannel brain neuromodulation system for treating neurological and neuropsychiatric disorders. It offers precise, personalized care by delivering stimulation to six branches of the occipital and trigeminal nerves via three adaptive output channels. This creates a cumulative effect by releasing neurotransmitters in the brainstem to modulate the brain networks associated with pain and mood control. The Relivion device is placed comfortably on the patient's head, where it stimulates the nerves. The connected e-Relief mobile app displays the treatment status and transmits information between patients and the cloud. In July 2019, Neurolief received the CE mark for Relivion, allowing the company to market, sell, and distribute the device as an over-the-counter therapy within the European Union and countries that participate with agreements on mutual recognition of conformity assessment.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Neurolief (נוירוליף) on @MedStartr Today #NeurologicalDisorders #ChronicPain #MigraineHeadache #Neurology #MedMo #MedStartrVentures

https://www.medstartr.ai/s/hcbGRK6wXCs

Get Involved in Neurolief (נוירוליף)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2013
Website: prolivrx.com/

Disease Areas

Neurological Disorders Chronic Pain Migraine & Headache

Technologies

Digital TherapeuticsNeuromodulationPlatformHome Healthcare

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Neurolief (נוירוליף)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.